| Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS
|
| TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
6q25.1 |
rSNP target |
0
|
TAS
|
| CHRNB4 |
cholinergic receptor, nicotinic beta 4 |
15q24 |
Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
0
|
TAS
|
| CHRNB3 |
cholinergic receptor, nicotinic beta 3 |
8p11.21 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
TAS
|
| APOB |
apolipoprotein B |
2p24-p23 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IDA; TAS
|
| UAP1 |
UDP-N-acetylglucosamine pyrophosphorylase 1 |
1q23.2 |
rSNP target |
0
|
IDA
|
| CLTC |
clathrin heavy chain |
17q23.1 |
rSNP target |
0
|
TAS
|
| CHRNA7 |
cholinergic receptor, nicotinic alpha 7 |
15q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IDA[12508119|16280133|21718690]; TAS
|
| CHRNA6 |
cholinergic receptor, nicotinic alpha 6 |
8p22 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
TAS
|
| OXTR |
oxytocin receptor |
3p25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
TAS
|
| UNC13C |
unc-13 homolog C (C. elegans) |
15q21.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
ISS
|
| RGS7 |
regulator of G-protein signaling 7 |
1q43 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IBA
|
| CHRNA5 |
cholinergic receptor, nicotinic alpha 5 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
2(1/1/0)
|
TAS
|
| NTM |
neurotrimin |
11q25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IEA
|
| CAV3 |
caveolin 3 |
3p25 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
IDA[17060380|20472890]; TAS
|
| LTA |
lymphotoxin alpha |
6p21.3 |
Mapped by Literature SNP |
0
|
TAS
|
| MYLIP |
myosin regulatory light chain interacting protein |
6p22.3 |
rSNP target |
0
|
IEA
|
| CHRNA3 |
cholinergic receptor, nicotinic alpha 3 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(0/1/0)
|
TAS
|
| HLA-F |
major histocompatibility complex, class I, F |
6p21.3 |
rSNP target |
0
|
IBA; TAS
|
| GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
15q12 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS
|
| TSPAN1 |
tetraspanin 1 |
1p33 |
rSNP target |
0
|
IDA[21836059]
|
| VIPR1 |
vasoactive intestinal peptide receptor 1 |
3p22 |
rSNP target |
0
|
TAS
|
| ADRB2 |
adrenoceptor beta 2 |
5q31-q32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IDA[9235896]; TAS
|
| AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
1q44 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IDA
|
| ZNRF2 |
zinc and ring finger 2, E3 ubiquitin protein ligase |
7p15.1 |
rSNP target |
0
|
IDA[22797923]
|
| NCAM1 |
neural cell adhesion molecule 1 |
11q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IDA; TAS
|
| CHRNA4 |
cholinergic receptor, nicotinic alpha 4 |
20q13.33 |
Literature-origin |
1(1/0/0)
|
ISS; TAS
|
| GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
| DRD3 |
dopamine receptor D3 |
3q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(1/1/0)
|
IDA[16386234|18424554|20531939]; TAS
|
| OR11L1 |
olfactory receptor family 11 subfamily L member 1 |
1q44 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
| CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
IDA[11206130]; TAS
|
| SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(11/10/0)
|
IDA[11343649|12958153]; TAS
|
| GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
Literature-origin |
1(0/0/1)
|
TAS
|
| GABRA2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
4p12 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(1/2/0)
|
TAS
|
| ADCYAP1R1 |
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
7p14.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
19(8/11/0)
|
TAS
|
| PIK3C2A |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha |
11p15.5-p14 |
rSNP target |
0
|
IDA[21081650]
|
| PRKCA |
protein kinase C, alpha |
17q24.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
10(9/0/1)
|
IDA[15632189|23990668]; TAS
|
| OPRL1 |
opiate receptor-like 1 |
20q13.33 |
Literature-origin, Mapped by Literature SNP |
0
|
TAS
|
| GJD2 |
gap junction protein delta 2 |
15q13.1 |
rSNP target |
0
|
TAS
|
| DEF6 |
DEF6, guanine nucleotide exchange factor |
6p21.33-p21.1 |
rSNP target |
0
|
IEA
|
| DRD4 |
dopamine receptor D4 |
11p15.5 |
Literature-origin, Mapped by Literature SNP |
7(2/5/0)
|
IDA[20531939]; TAS
|
| KCNC1 |
potassium channel, voltage gated Shaw related subfamily C, member 1 |
11p15 |
rSNP target |
0
|
TAS
|
| FASLG |
Fas ligand |
1q23 |
Literature-origin |
1(0/0/1)
|
IDA[12201652]
|
| NDRG1 |
N-myc downstream regulated 1 |
8q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IDA[12432451]
|
| APOA1 |
apolipoprotein A-I |
11q23-q24 |
Mapped by LD-proxy |
0
|
TAS
|
| TRAF7 |
TNF receptor associated factor 7 |
16p13.3 |
rSNP target |
0
|
IDA
|
| TRPA1 |
transient receptor potential cation channel, subfamily A, member 1 |
8q13 |
rSNP target |
0
|
TAS
|
| DPP6 |
dipeptidyl-peptidase 6 |
7q36.2 |
Literature-origin, Mapped by Literature SNP |
1(0/0/1)
|
ISS
|
| LIN7C |
lin-7 homolog C (C. elegans) |
11p14 |
rSNP target |
0
|
IDA[23201090]; TAS
|
| COMT |
catechol-O-methyltransferase |
22q11.21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(9/12/0)
|
TAS
|
| GHRHR |
growth hormone releasing hormone receptor |
7p14 |
rSNP target |
0
|
IDA[10461027]; TAS
|
| PLXNC1 |
plexin C1 |
12q23 |
Literature-origin |
1(0/0/1)
|
TAS
|
| PTPRT |
protein tyrosine phosphatase, receptor type T |
20q12-q13 |
Literature-origin, Mapped by Literature SNP |
1(0/0/1)
|
IDA[18644975]
|
| TNF |
tumor necrosis factor |
6p21.3 |
Mapped by Literature SNP |
1(1/0/0)
|
TAS
|
| TULP1 |
tubby like protein 1 |
6p21.3 |
Mapped by LD-proxy |
0
|
IDA[16303976]
|
| ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
10q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(2/0/0)
|
ISS
|
| LGR6 |
leucine-rich repeat containing G protein-coupled receptor 6 |
1q32.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
| CLIC1 |
chloride intracellular channel 1 |
6p21.3 |
rSNP target |
0
|
IEA
|
| MICB |
MHC class I polypeptide-related sequence B |
6p21.3 |
rSNP target |
0
|
IBA; TAS
|
| SLC4A5 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 5 |
2p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
| NUCB2 |
nucleobindin 2 |
11p15.1 |
rSNP target |
0
|
TAS[7811391]
|
| PARD6B |
par-6 family cell polarity regulator beta |
20q13.13 |
rSNP target |
0
|
IDA[12545177]; TAS
|
| ITGA6 |
integrin subunit alpha 6 |
2q31.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IDA[21310825]; TAS
|
| MAPT |
microtubule associated protein tau |
17q21 |
Mapped by LD-proxy, rSNP target |
0
|
IDA[8522593]
|
| SDC2 |
syndecan 2 |
8q22-q23 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
| OR2L13 |
olfactory receptor family 2 subfamily L member 13 |
1q44 |
Literature-origin |
1(0/0/1)
|
TAS
|
| LTB |
lymphotoxin beta |
6p21.3 |
rSNP target |
0
|
TAS
|
| ARHGAP21 |
Rho GTPase activating protein 21 |
10p12.31 |
rSNP target |
0
|
IEA
|
| ABCC1 |
ATP binding cassette subfamily C member 1 |
16p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IDA; TAS
|
| CRHR1 |
corticotropin releasing hormone receptor 1 |
17q21.31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
12(6/6/0)
|
TAS
|
| CHRNA2 |
cholinergic receptor, nicotinic alpha 2 |
8p21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
TAS
|
| ARVCF |
armadillo repeat gene deleted in velocardiofacial syndrome |
22q11.21 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
IEA
|
| LRPAP1 |
LDL receptor related protein associated protein 1 |
4p16.3 |
Literature-origin |
1(0/0/1)
|
IDA[16263759]
|
| ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
| SLC20A2 |
solute carrier family 20 (phosphate transporter), member 2 |
8p11.21 |
rSNP target |
0
|
TAS
|
| C8orf37 |
chromosome 8 open reading frame 37 |
8q22.1 |
Literature-origin |
1(0/0/1)
|
IDA
|
| RGS2 |
regulator of G-protein signaling 2 |
1q31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
7(2/5/0)
|
IBA; IDA[11278586]
|
| VASP |
vasodilator-stimulated phosphoprotein |
19q13.32 |
Mapped by Literature SNP |
0
|
IDA
|
| HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
5q12.3 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
TAS
|
| PAQR7 |
progestin and adipoQ receptor family member VII |
1p35.3 |
Mapped by LD-proxy, rSNP target |
0
|
IBA
|
| SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
44(13/31/0)
|
IDA[16870614|17506858|18227069|19270731]
|
| GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS
|
| SLC6A2 |
solute carrier family 6 (neurotransmitter transporter), member 2 |
16q12.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
13(4/9/0)
|
TAS
|
| SLC18A2 |
solute carrier family 18 (vesicular monoamine transporter), member 2 |
10q25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(2/1/0)
|
TAS
|
| APOE |
apolipoprotein E |
19q13.31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
6(2/4/0)
|
TAS
|
| HLA-G |
major histocompatibility complex, class I, G |
6p21.3 |
Mapped by LD-proxy |
0
|
IBA; TAS
|
| DRD2 |
dopamine receptor D2 |
11q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
18(11/7/0)
|
TAS
|
| GML |
glycosylphosphatidylinositol anchored molecule like |
8q24.3 |
Mapped by Literature SNP |
0
|
IEA
|
| RAB5A |
RAB5A, member RAS oncogene family |
3p24.3 |
rSNP target |
0
|
IBA
|
| NLGN1 |
neuroligin 1 |
3q26.32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
ISS
|
| CAT |
catalase |
11p13 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IEA
|
| HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(2/2/0)
|
IDA[15862800|18703043]; TAS
|
| CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
TAS
|
| IL2RA |
interleukin 2 receptor subunit alpha |
10p15-p14 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
TAS
|
| COBL |
cordon-bleu WH2 repeat protein |
7p12.2-p12.1 |
Literature-origin |
2(1/1/0)
|
ISS
|
| PRKG1 |
protein kinase, cGMP-dependent, type I |
10q11.2 |
Literature-origin, Mapped by Literature SNP |
1(0/0/1)
|
IDA[16990611|21402151]
|
| ARRB1 |
arrestin, beta 1 |
11q13 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS[9924018]
|
| CRHR2 |
corticotropin releasing hormone receptor 2 |
7p14.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(2/0/0)
|
TAS
|
| VMP1 |
vacuole membrane protein 1 |
17q23.1 |
rSNP target |
0
|
IEA
|
Basic Info
